FDA is playing a dangerous game of chicken here! CytoDyn has no need for the US regulators forcing them into underpowered and under-dosed trials anymore. -1500- will get you a p-value that even old Woodcock can't ignore! Readout in Nov-Dec, but I'm willing to bet 40% gets hit much, much sooner.